In a recent government meeting, officials discussed the implementation of a new policy regarding the emergency use of Naloxone, a medication designed to reverse opioid overdoses. Dr. Stewart, the lead on the initiative, presented the policy for approval, highlighting that it aligns with similar measures already in place in Wake County. The policy aims to ensure that Naloxone is readily available in all schools, alongside other emergency medical supplies.

The discussion revealed that all school nurses have undergone training to administer Naloxone, and law enforcement officers, including School Resource Officers (SROs), are also equipped with the medication. The anticipated response time for accessing Naloxone in emergencies is approximately 90 seconds, a critical factor in life-saving situations.

Board members raised several points during the meeting. One member suggested clarifying that Naloxone should be used regardless of the presence of CPR-certified individuals, emphasizing that the priority should be saving lives. Another proposal was to extend the policy's applicability beyond school hours, allowing for its use whenever individuals are present on school grounds.

Concerns were also voiced regarding the language in the policy that states the board cannot guarantee the availability of trained personnel or Naloxone at every school site. This statement was seen as potentially undermining the policy's effectiveness. Dr. Stewart explained that while the district aims to maintain a steady supply of Naloxone, it cannot ensure that it will always be available.

The board discussed the importance of training, noting that only personnel who have completed the necessary training would be authorized to administer Naloxone. However, there was a consensus that individuals with their own supplies of Naloxone should not be prohibited from using it in emergencies, as the primary goal is to save lives.

The meeting concluded with a recognition of the legal protections in place for school employees administering first aid, which may extend to the use of Naloxone. The board is expected to revisit the policy for further refinement and approval in upcoming sessions.